TABLE 4.
Association of homozygosity at HLA class I loci with CD8+ CTL response to ALVAC-HIV canarypox vaccinea
| Locusb | HIV proteinc | No. (%) of persons at 2 wks after 3rd or 4th dose (wk 26)
|
ORd | |
|---|---|---|---|---|
| Homozygous | Heterozygous | |||
| HLA-A | Any | 3 (9) | 31 (13) | 0.7 |
| Gag | 3 (16) | 16 (15) | 1.3 | |
| Env | 2 (10) | 18 (17) | 1.2 | |
| HLA-B | Any | 3 (12) | 22 (10) | 1.1 |
| Gag | 3 (18) | 14 (13) | 1.6 | |
| Env | 1 (6) | 16 (14) | 0.6 | |
See text for typing details; a total of 273 and 285 were unambiguously typed to the four-digit level at the A and B loci, respectively.
Vaccine-specific viral protein against which CTL response was measured.
All P values were >0.15.